Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal Metastasis

Clinical trial NCT06809517 · RECRUITING

Trial details

NCT number: NCT06809517
Sponsor: Guangzhou Medical University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leptomeningeal Metastasis Intrathecal Drug Delivery

Start date: 2025-03-18
Primary completion: 2026-03-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.